{"public_id":"cl_a36e5890188d474ef7b490f46f0d5ad8","status":"active","superseded_by_public_id":null,"corpus_id":25100921,"text":"Positive early interim FDG-PET after two courses of ABVD is strongly associated with much poorer 2-year progression-free survival than negative PET-2 in advanced Hodgkin's lymphoma.","confidence":0.98,"paper":{"corpus_id":25100921,"title":"Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study.","url":"https://sah.borca.ai/papers/25100921"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.98,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_62ce44e75c1b0a4ff2768b96fcaa1e0b","name":"ABVD therapy","description":"A standard chemotherapy regimen consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine.","types":["treatment regimen"],"url":"https://sah.borca.ai/concepts/co_62ce44e75c1b0a4ff2768b96fcaa1e0b"},{"public_id":"co_8b89d4ce4236ac8e7740deb30b8bce7d","name":"progression-free survival","description":"The time during and after treatment in which patients remain alive without disease progression or relapse.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_8b89d4ce4236ac8e7740deb30b8bce7d"},{"public_id":"co_a7a3894478d4f5347be438d8c3d9bef2","name":"FDG-PET scan","description":"An interim fluorodeoxyglucose positron emission tomography examination used to assess disease activity after initial chemotherapy.","types":["measurement technique","prognostic test"],"url":"https://sah.borca.ai/concepts/co_a7a3894478d4f5347be438d8c3d9bef2"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_a36e5890188d474ef7b490f46f0d5ad8"}